Avon Products, Inc. (NYSE:AVP) enjoyed a 120% run-up in share price since hitting record low of $1.3. The stock managed 4% rise and now stands at $2.86 as of 3/14/2019. At a recent session, the prices were hovering between $2.745 and $2.88. This company shares are -5.24% up from its target price of $2.71 and the current market capitalization stands at $1.27B. The recent change has given its price a 19.76% lead over SMA 50 and -16.13% deficit over its 52-week high. The stock witnessed 4.38% gains, 52.13% gains and 45.18% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found AVP’s volatility during a week at 4.76% and during a month it has been found around 7.62%.

Avon Products, Inc. (AVP) Top Holders

Institutional investors currently hold around $912 million or 77.4% in AVP stock. Look at its top three institutional owners: Blackrock Inc. owns $119.99 million in Avon Products, Inc., which represents roughly 9.45% of the company’s market cap and approximately 13.16% of the institutional ownership. Similar statistics are true for the second largest owner, Miller Value Partners, Llc, which owns 27,758,588 shares of the stock are valued at $76.34 million. The third largest holder is Yacktman Asset Management Lp, which currently holds $52.52 million worth of this stock and that ownership represents nearly 4.14% of its market capitalization.

Avon Products, Inc. 13F Filings

At the end of December reporting period, 100 institutional holders increased their position in Avon Products, Inc. (NYSE:AVP) by some 19,736,824 shares, 98 decreased positions by 24,146,289 and 55 held positions by 287,864,773. That puts total institutional holdings at 331,747,886 shares, according to SEC filings. The stock grabbed 26 new institutional investments totaling 2,624,145 shares while 25 institutional investors sold out their entire positions totaling 3,262,265 shares.

Avon Products, Inc. (AVP) Analyst Guide

Several analysts have released their opinion on Avon Products, Inc. (NYSE:AVP), with 2 analysts believing it is a strong buy. Whereas 7 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.5 average brokerage recommendation [T1].